Page last updated: 2024-10-18

dihydrouracil and Adenocarcinoma, Basal Cell

dihydrouracil has been researched along with Adenocarcinoma, Basal Cell in 1 studies

hexahydropyrimidine-2,4-dione: structure in first source
5,6-dihydrouracil : A pyrimidine obtained by formal addition of hydrogen across the 5,6-position of uracil.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mounier-Boutoille, H1
Boisdron-Celle, M1
Cauchin, E1
Galmiche, JP1
Morel, A1
Gamelin, E1
Matysiak-Budnik, T1

Other Studies

1 other study available for dihydrouracil and Adenocarcinoma, Basal Cell

ArticleYear
Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation.
    British journal of clinical pharmacology, 2010, Volume: 70, Issue:2

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Colonic Neoplasms; Dihydropyrimidine Dehydrog

2010